24 results on '"PAVONE MACALUSO M"'
Search Results
2. PROSPECTIVE, RANDOMIZED, CROSSOVER COMPARISON OF SUBLINGUAL APOMORPHINE (3 mg) WITH ORAL SILDENAFIL (50 mg) FOR MALE ERECTILE DYSFUNCTION
3. Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience
4. A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER
5. ROLE OF ANTIMICROBIAL TREATMENT IN PATIENTS WITH ELEVATED PSA AND NORMAL DIGITAL RECTAL EXAMINATION
6. LOW-DOSE ORAL CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CARCINOMA (HRPC). ESTRAMUSTINE PHOSPHATE VERSUS ESTRAMUSTINE PHOSPHATE AND ETOPOSIDE. A RANDOMISED PHASE II STUDY OF GSTU FOUNDATION
7. 871Water chlorination and other environmental factors in bladder cancer. Result of a multicentre study
8. 827 Environmental factors in superficial bladder cancer. Preliminary report of a prospective study
9. 479 Intravesical gemcitabine in superficial bladder tumours. Results of a phase I–II study
10. Intravesical gemcitabine in superficial bladder tumours. Preliminary results of a phase I–II study
11. Risk factor analysis in 165 selected patients with T1G3 transitional cell carcinoma of the bladder treated by TUR plus adjuvant intravesical therapy
12. The role of neoadjuvant or adjuvant chemotherapy for invasive bladder cancer: Is there a benefit for survival or preserving the bladder?
13. Bladder cancer
14. Genitourinary group phase II study of chemotherapy in stage T3-4 N0-X M0 transitional cell cancer of the bladder: Prognostic factor analysis
15. Factors affecting recurrence and progression in superficial bladder tumours
16. Recombinant alpha interferon inmetastatic renal cell carcinoma a cooperative phase II study
17. Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder
18. A European Organization for Research and Treatment of Cancer—Genitourinary Group Phase 2 Study of Chemotherapy in Stage T3-4N0-XM0 Transitional Cell Cancer of the Bladder: Evaluation of Clinical Response
19. Monotherapy with Nilutamide, A Pure Nonsteroidal Antiandrogen, in Untreated Patients with Metastatic Carcinoma of the Prostate
20. DIALYTIC PARABIOSIS: A New Method of Treating Renal Failure by the Extrarenal Route, Using a Mammalian Donor
21. 296 - Timing of hormonal therapy in prostate cancer
22. Re: Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762, by H. J. deVoogt, P. H. Smith, M. Pavone-Macaluso, M. de Pauw, S. Suciu and Members of the European Organization for Research on Treatment of Cancer Urological Group, J. Urol., 135: 303–307, 1986. Re: Comparison of Diethylstilbestrol, Cyproterone Acetate and Medroxyprogesterone Acetate in the Treatment of Advanced Prostatic Cancer: Final Analysis of Randomized Phase III Trial of the European Organization for Research on Treatment of Cancer Urological Group, by M. Pavone-Macaluso, H. J. deVoogt, G. Viggiano, E. Barasolo, B. Lardennois, M. de Pauw and R. Sylvester, J. Urol., 136: 624–631, 1986
23. AN ARTIFICIAL PLACENTA
24. SEPTICÆMIA DUE TO GRAM-NEGATIVE BACILLI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.